Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1997-50-8

Post Buying Request

1997-50-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1997-50-8 Usage

Uses

5-Fluoro-8-Quinolinesulfonyl Chloride may act as a clastogenic compound as well as inhibitor of CYP enzymes due to the quinoline moiety in the substructure. This also leads to antibacterial properties being displayed by the molecule.

Check Digit Verification of cas no

The CAS Registry Mumber 1997-50-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,9 and 7 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1997-50:
(6*1)+(5*9)+(4*9)+(3*7)+(2*5)+(1*0)=118
118 % 10 = 8
So 1997-50-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H5ClFNO2S/c10-15(13,14)8-4-3-7(11)6-2-1-5-12-9(6)8/h1-5H

1997-50-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-fluoroquinoline-8-sulfonyl chloride

1.2 Other means of identification

Product number -
Other names 5-Fluoro-quinoline-8-sulfonyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1997-50-8 SDS

1997-50-8Downstream Products

1997-50-8Relevant articles and documents

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 179; 180, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 192; 193, (2014/09/29)

Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1997-50-8